THE GINGIVITIS ASSOCIATED WITH PREGNANCY has been attributed to increa
sed concentrations of circulating estrogen and/or progesterone. Howeve
r, the mechanism by which these steroids increase gingival inflammatio
n is not known. Interleukin-6 (IL-6), a pleiotropic cytokine produced
by many cell types including human gingival fibroblasts (hGF), is secr
eted in response to inflammatory challenges such as bacterial lipopoly
saccharide and interleukin-l (IL-1). This study tested the hypothesis
that progesterone could modulate the local production of IL-6 by hGF.
The effects of progesterone on IL-6 production were measured in vitro
in serum-free, phenol red-free medium to eliminate possible effects of
such medium additives. The concentration of IL-6 secreted into supern
atant medium after a 24 hour challenge with IL-1 beta was estimated by
radioimmunoassay. Total RNA from steroid-treated hGF was probed for I
L-6 mRNA. In serum-free medium, progesterone dose-dependently and sign
ificantly (P<0.05) inhibited IL-6 production by hGF, as did the glucoc
orticoids hydrocortisone (HC) and dexamethasone. At progesterone conce
ntrations common in late pregnancy, IL-6 production was reduced to lev
els 40 to 50% of control. In addition, mRNA was significantly down-reg
ulated by progesterone and HC, at both basal levels and after IL-1 bet
a challenge. These results suggest that high levels of progesterone du
ring pregnancy affect the development of localized inflammation by: do
wn-regulation of IL-6 production, rendering the gingiva less efficient
at resisting the inflammatory challenges produced by bacteria.